Community Contributor
Member since 2020
Views
0 Total number of views
Fair Values Set
0 Total number of fair values set
Comments
1 Total number of comments
Followers
0 Total number of followers

No bio added yet

No link added
US$415.54
52.2% undervalued intrinsic discount
Fair Value
Revenue
55% p.a.
Profit Margin
25%
Future PE
35x
Price in 2031
US$700.2
TLX logo
Telix Pharmaceuticals

TLX... a Market's Overreaction or a Falling Knife?

So just for context to any investors happening upon this narrative... What does Telix actually do?Read more

View narrative
AU$18
20.7% undervalued intrinsic discount
Fair Value
Profit Margin
13%
Future PE
27.9x
Price in 2029
AU$22.19
US$324.48
9.9% overvalued intrinsic discount
Fair Value
Revenue
12% p.a.
Profit Margin
35%
Future PE
23x
Price in 2030
US$476.77
US$173.02
83.9% undervalued intrinsic discount
Fair Value
Revenue
36.3% p.a.
Profit Margin
10%
Future PE
60x
Price in 2030
US$242.66
US$345.07
41.8% undervalued intrinsic discount
Fair Value
Revenue
25.01% p.a.
Profit Margin
53.01%
Future PE
43.82x
Price in 2030
US$567.87
US$17.37
59.8% undervalued intrinsic discount
Fair Value
Profit Margin
30%
Future PE
45x
Price in 2030
US$67.56
US$1.48k
44.4% undervalued intrinsic discount
Fair Value
Revenue
31% p.a.
Profit Margin
52%
Future PE
20x
Price in 2031
US$3.11k
US$107.02
15.0% overvalued intrinsic discount
Fair Value
Revenue
32.43% p.a.
Profit Margin
38%
Future PE
62x
Price in 2031
US$149.28